Showing results (121-130 of 294) with videos related to
Sort By:
Pageof 30
Clinical Chemistry|June 10, 2008
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurementsOrlando M Gutiérrez, Hector Tamez, Ishir Bhan, et al.The Journal of Clinical Endocrinology and Metabolism|December 8, 2009
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically activeTakashi Shimada, Itaru Urakawa, Tamara Isakova, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2020
Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance HemodialysisDaniel L Edmonston, Tamara Isakova, Laura M Dember, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 17, 2019
Pulmonary Hypertension Subtypes and Mortality in CKDDaniel L Edmonston, Kishan S Parikh, Sudarshan Rajagopal, et al.Bone|July 31, 2020
Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiencyRebecca Frazier, Alexander Hodakowski, Xuan Cai, et al.Kidney International|June 19, 2009
Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery diseasePatrick H Pun, Thomas R Smarz, Emily F Honeycutt, et al.Journal of Primary Care & Community Health|August 15, 2024
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by NephrologistsAnjay Rastogi, Ashté Collins, Ellie Kelepouris, et al.Clinical Nephrology|November 15, 2012
Sudden cardiac arrest in ESRD patientsSikander P Surana, Patrick H Pun, Sai Ram Keithi-Reddy, et al.Advances in Kidney Disease and Health|November 22, 2024
Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US NephrologistsAnjay Rastogi, Glenn M Chertow, Ashté Collins, et al.The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsiaRavi Thadhani, Walter P Mutter, Myles Wolf, et al.Pageof 30